GB1419692A - - Google Patents

Info

Publication number
GB1419692A
GB1419692A GB1143273A GB1143273A GB1419692A GB 1419692 A GB1419692 A GB 1419692A GB 1143273 A GB1143273 A GB 1143273A GB 1143273 A GB1143273 A GB 1143273A GB 1419692 A GB1419692 A GB 1419692A
Authority
GB
United Kingdom
Prior art keywords
alkyl
amino
formulae
benzyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1143273A
Inventor
William Watson Briner
Robert James Granger
James Stone Widder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19732310772 priority Critical patent/DE2310772A1/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to BE128587A priority patent/BE796532A/en
Priority to GB1143273A priority patent/GB1419692A/en
Priority to JP48034186A priority patent/JPS49118839A/ja
Publication of GB1419692A publication Critical patent/GB1419692A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

1419692 Oral compositions PROCTER & GAMBLE CO 9 March 1973 11432/73 Heading A5B An oral composition effective in inhibiting the formation of dental calculus comprises (1) from 0.01% to 10% by weight of an anticalculus agent selected from those of the formulae: wherein R 1 and R 2 are H or CH 2 OH; n is an integer of from 3 to 10; R 3 is H, C 1 -C 20 alkyl, C 2 -C 20 alkenyl, aryl, phenylethenyl, benzyl, halogen, amino, dimethyl amino, diethylamino, N-hydroxy-N-ethylamino, acetylamino, -CH 2 COOH, CH 2 PO 3 H 2 , -CH(PO 3 H 2 )(OH) or -CH 2 CH(PO 3 H 2 ) 2 ; and R 4 is H, C 1 -C 6 alkyl, amino, benzyl, halogen, hydroxyl, -CH 2 CO OH, -CH 2 PO 3 H 2 , or CH 2 CH 2 PO 3 H 2 ; wherein R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each H or C 1 -C 6 alkyl; wherein n is an integer from 3 to 9; wherein X and Y are each H or hydroxy; or an orally acceptable salt thereof; or the condensation products of ammonia and phosphorous pentoxide having the formulae: and (2) from 0.5 to 95% by weight of a compatible silica xerogel abrasive, the pH of the composition being within the range of 5.0 to 11.0.
GB1143273A 1973-03-03 1973-03-09 Expired GB1419692A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19732310772 DE2310772A1 (en) 1973-03-03 1973-03-03 ORAL COMPOSITION FOR INHIBITION OF DENTISTAL FORMATION
BE128587A BE796532A (en) 1973-03-03 1973-03-09 ANTI-CALCULATION ORAL COMPOSITIONS
GB1143273A GB1419692A (en) 1973-03-03 1973-03-09
JP48034186A JPS49118839A (en) 1973-03-03 1973-03-27

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19732310772 DE2310772A1 (en) 1973-03-03 1973-03-03 ORAL COMPOSITION FOR INHIBITION OF DENTISTAL FORMATION
GB1143273A GB1419692A (en) 1973-03-03 1973-03-09

Publications (1)

Publication Number Publication Date
GB1419692A true GB1419692A (en) 1975-12-31

Family

ID=25764778

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1143273A Expired GB1419692A (en) 1973-03-03 1973-03-09

Country Status (4)

Country Link
JP (1) JPS49118839A (en)
BE (1) BE796532A (en)
DE (1) DE2310772A1 (en)
GB (1) GB1419692A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364658A1 (en) * 1976-09-15 1978-04-14 Huber Corp J M PREPARATION OF THERAPEUTIC TOOTHPASTE THAT MAY BE CONTAINED IN AN UNSHIRT CONTAINER, AND PRODUCTS OBTAINED
EP1188441A1 (en) * 1999-06-02 2002-03-20 Sumitomo Pharmaceuticals Company, Limited Oral preparations of etidronate disodium

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011663B1 (en) * 1978-12-01 1982-12-08 Unilever Plc Toilet and dental preparations and their use for oral and dental hygiene

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364658A1 (en) * 1976-09-15 1978-04-14 Huber Corp J M PREPARATION OF THERAPEUTIC TOOTHPASTE THAT MAY BE CONTAINED IN AN UNSHIRT CONTAINER, AND PRODUCTS OBTAINED
EP1188441A1 (en) * 1999-06-02 2002-03-20 Sumitomo Pharmaceuticals Company, Limited Oral preparations of etidronate disodium
EP1188441A4 (en) * 1999-06-02 2004-01-28 Procter & Gamble Oral preparations of etidronate disodium

Also Published As

Publication number Publication date
BE796532A (en) 1973-09-10
DE2310772A1 (en) 1974-09-12
JPS49118839A (en) 1974-11-13

Similar Documents

Publication Publication Date Title
GB1263934A (en) Oral compositions for calculus retardation
GB1232889A (en)
GB1448942A (en) Compositions for radiographic scanning
ES8506729A1 (en) New cephem compounds and processes for preparation thereof.
GB1501827A (en) Composition for use in the production of 99m technetium radio-diagnostics
PT71709A (en) PROCESS FOR THE PREPARATION OF NEW DENTIFRING COMPOSITIONS FOR THE DETECTION OF THE PRESENCE AND THE INHIBITION OF DENTAL TARTAR
HUP9802408A2 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
UA27108A1 (en) Anthracycline glycosides and their pharmaceutically acceptable acid-additive salts, method of their synthesis, diiodointermediate compound and method of its synthesis
ES416478A1 (en) Oral compositions for plaque caries and calculus retardation with reduced staining tendencies
GB1419692A (en)
GB1369249A (en) Amines the preparation thereof and their use in pharmaceutical compositions
IE43139L (en) Bis-biguanide compounds
IE41307L (en) Oral compositions for plaque caries, and calculus retardation
IL57926A (en) Alkoxyphenylpyrrolidones,processes for their manufacture and pharmaceutical compositions containing the same
ES8404852A1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use.
ES8305685A1 (en) Amphoteric fatty acid-amino acid salts and their use in detergent compositions
GB1344815A (en) Oral compositions
ES461785A1 (en) Behenic acid esters, compositions thereof and a method of preparation thereof
ES8503348A1 (en) Prostacycline derivatives, process for their preparation and their use as medicines.
ES8308331A1 (en) Cephalosporin derivatives substituted in position 3 with a thiomethylheterocyclic group, process for their preparation and pharmaceutical compositions containing them.
GB1421064A (en) Oral compositions for calculus retardation
ES8500054A1 (en) Sulfamoyl benzophenon derivatives, process for their preparation, their use, and pharmaceutical compositions based on these compounds.
HUP9801750A2 (en) Water-soluble polymyxin-b conjugates, process for producing them, and pharmaceutical compositions containing said conjugates
KR960014780B1 (en) Dental plaque inhibitor composition and its preparation
ES8507123A1 (en) 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine derivatives, process for their preparation and their therapeutical use

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee